Cynata Expands MEND clinical trial in COVID-19 and Respiratory Failure

NEXT STORY
SCYNEXIS Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
PREV STORY
TG Therapeutics Completes Rolling Submission of Biologics License Application to the U.S. Food and Drug Administration for Ublituximab in Combination with UKONIQ™(umbralisib) as a Treatment for Patients with Chronic Lymphocytic Leukemia
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

OliX Pharmaceuticals Expands Scientific Advisory Board with Addition of Leading Liver Experts

author_avatar
NASDAQ Market News

R1 RCM Reports Third Quarter 2020 Results

author_avatar
NASDAQ Market News

Allena Pharmaceuticals to Present New Data on Reloxaliase and ALLN-346 Development Programs at Upcoming ASN Kidney Week and ACR/ARP Annual Meeting

author_avatar
NASDAQ Market News